Bright Uro key facts
as of Oct 2026- Developer of a wireless, catheter-free, urodynamic monitoring system designed to improve the diagnosis and management of lower urinary tract symptoms.
- Bright Uro is valued at approximately $92.0M as of Oct 2026, set at its early-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $47.0M across 2 recorded rounds; the latest was Early Stage VC ($15.0M) in Jun 2025.
- Notable investors include MedTech Innovator, University of California, AIN Ventures, Academy Investor Network, Device of Tomorrow Capital — 11 tracked in total.
- Bright Uro has filed 6 Form Ds with the SEC since 2023, most recently Sep 2025 ($15.0M sold to 35 investors).
- Status: Privately Held (backing).
Valued at $92.0M at its early-stage round, Jun 2025. Nothing has traded since.
- ·The complete investor list: 11 names
- ·Watch Bright Uro: the Monday email on marks, rounds and moves
Bright Uro funding rounds
2 roundsWho backs Bright Uro
11+Membership and data by Private Market View
Bright Uro valuation
Bright Uro was valued at $92 million at its early-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Bright Uro raised?
Bright Uro has raised $47 million across 2 recorded rounds since 2023. The largest was a $31 million early-stage round in Nov 2023; the most recent was a $15 million early-stage round in Jun 2025.
Bright Uro has filed 6 Form Ds with the SEC since 2023, most recently in Sep 2025 ($15 million sold to 35 investors).
Bright Uro investors
11 investors are on record for Bright Uro, including MedTech Innovator, University of California, AIN Ventures and Academy Investor Network. The early-stage round in Jun 2025 drew 35 investors.
About Bright Uro
Developer of a wireless, catheter-free, urodynamic monitoring system designed to improve the diagnosis and management of lower urinary tract symptoms. The company's system offers cloud-based data access and a streamlined digital workflow for enhancing treatment decisions and patient experience by allowing spontaneous voiding in a natural setting, enabling clinicians and patients facing bladder control issues to achieve more accurate and comfortable diagnostic assessments.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2021
- Employees
- 44
- Website
- gleanuds.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.